Rehabilitation bei Coronavirus-Erkrankung mit SARS-CoV-2 (COVID-19)

Eine Coronavirus-Erkrankung mit SARS-CoV-2 (COVID-19) mit ihren unterschiedlichen Verläufen von mild bis kritisch ist häufig nicht nur eine akute Erkrankung, sondern führt darüber hinaus bei einem Teil der Betroffenen zu Organschäden und Körperfunktionsstörungen, die auch nach der Akutphase fortbestehen. Wenn die Gesundheitsfolgen die Selbstständigkeit im Alltag oder die beruflichen Fähigkeiten einschränken, ist eine spezifische rehabilitative Behandlung angezeigt.

Abstract

The Coronavirus disease with SARS-CoV-2 viral infection (COVID-19) and its diverse courses of disease from mild to critical illness frequently is not only an acute disease, but will – in a proportion of those affected – lead to organ structure and body function deficits that still exist or become apparent after the acute stage of disease. When clinically relevant symptoms or functional deficits (impairments) are documented more than four weeks after COVID-19 onset, the syndrome is called “Long-COVID”, from 12 weeks after onset onwards “Post-COVID”.

In such cases and when everyday life functioning or return to work are affected by persisting deficits specialized rehabilitation treatment is indicated. An individual medical, frequently multi-professional diagnostic evaluation is mandatory in that situation: For adequate treatment, it is important to identify and objectify the individually underlying health conditions based on knowledge about the diverse potential consequences of COVID-19, to assess type and severity of functional consequences (impairments, activity limitations, and restrictions of participation) of Long-/Post-COVID individually, and then to decide on the treatment necessities and plans. With regard to rehabilitation, need and decision for either pulmonary, neurological, cardiac, or psychosomatic rehabilitation depends on the individual medical presentation.

Schlüsselwörter

SARS-CoV-2 - Rehabilitation - COVID-19 - Post-COVID - Long-COVID

Key words

SARS-CoV-2 - rehabilitation - COVID-19 - post-COVID - long-COVID

Publication History

Article published online:
01 August 2022

• Literatur

• 1 Koczulla AR, Ankermann T, Behrends U. et al AWMF S1-Leitlinie Post-COVID/Long-COVID. AWMF-Registernummer 020-027; 12.07.2021. Im Internet (Stand 21.04.2022): https://www.awmf.org/leitlinien/detail/anmeldung/1/ll/020-027.html
• 2 Platz T, Berghem S, Berlit P. et al S2k-Leitlinie SARS-CoV-2, COVID-19 und (Früh-)Rehabilitation. Deutsche Gesellschaft für Neurorehabilitation, Hrsg. AWMF-Registernummer 080-008; Version 2 vom 1.11.2021. Im Internet (Stand: 16.05.2022): https://www.awmf.org/leitlinien/detail/ll/080–008.html
• 3 Glöckl R, Buhr-Schinner H, Koczulla AR. et al. DGP-Empfehlungen zur pneumologischen Rehabilitation bei COVID-19. Pneumologie 2020; 74: 496-504 DOI: 10.1055/a-1193-9315.
• 4 Lehmann A, Prosch H, Zehetmayer S. et al. Impact of persistent D-dimer elevation following recovery from COVID-19. PLoS One 2021; 16: e0258351 DOI: 10.1371/journal.pone.0258351.
• 5 Koczulla AR, Stegemann A, Gloeckl R. et al. Newly detected rapid eye movement associated sleep apnea after coronavirus disease 2019 as a possible cause for chronic fatigue: two case reports. J Med Case Rep 2021; 15: 211 DOI: 10.1186/s13256-021-02819-0.
• 6 Meyer FJ, Borst MM, Buschmann HC. et al Belastungsuntersuchungen in der Pneumologie – Empfehlungen der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. Pneumologie 2018; 72: 687-731
• 7 Liu K, Zhang W, Yang Y. et al. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract 2020; 39: 101166 DOI: 10.1016/j.ctcp.2020.101166.
• 8 Glöckl R, Leitl D, Jarosch I. et al. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Research 2021; 7 DOI: 10.1183/23120541.00108-2021.
• 9 Hayden M, Limbach M, Schuler M. et al. Effectiveness of a Three-Week Inpatient Pulmonary Rehabilitation Program for Patients after COVID-19: A Prospective Observational Study. Int J Environ Res Public Health 2021; 18: 9001 DOI: 10.3390/ijerph18179001.
• 10 Sonnenweber T, Sahanic S, Pizzini A. et al. Cardiopulmonary Recovery after COVID-19: an observational prospective multicenter trial. Eur Respir J 2021; 57: 2003481 DOI: 10.1183/13993003.03481-2020.
• 11 Luger AK, Sonnweber T, Gruber L. et al. Chest CT of Lung Injury 1 Year after COVID-19 Pneumonia: The CovILD Study. DOI: 10.1148/radiol.211670.
• 12 Leo F, Meybaum C, Wormanns D. et al. Update 2021: Pulmonale Folgen nach COVID-19-Pneumonie. Dtsch Med Wochenschr 2021; 146: 927-932
• 13 Chou SH, Beghi E, Helbok R. et al. Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19 – A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw Open 2021; 4: e2112131 DOI: 10.1001/jamanetworkopen.2021.12131.
• 14 Heesakkers H, van der Hoeven JG, Corsten S. Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19. JAMA 2022; 327: 559-565 DOI: 10.1001/jama.2022.0040.
• 15 Wahlgren C, Divanoglou A, Larsson M. et al. Rehabilitation needs following COVID-19: Five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms. EClinicalMedicine 2022; 43: 101219 DOI: 10.1016/j.eclinm.2021.101219.
• 16 Kedor C, Freitag H, Meyer-Arndt L. et al. Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany – a first analysis of a prospective observational study. medRxiv 2021; DOI: 10.1101/2021.02.06.21249256.
• 17 Rass V, Beer R, Schiefecker AJ. et al. Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur J Neurol 2021; 28: 3348-3359 DOI: 10.1111/ene.14803.
• 18 Platz T. Hrsg. Update Neurorehabilitation 2022. Bad Honnef: Hippocampus Verlag; 2022
• 19 Boukhris M, Hillani A, Moroni F. et al. Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective. Can J Cardiol 2020; 36: 1068-1080 DOI: 10.1016/j.cjca.2020.05.018.
• 20 Pecci C, Ajmal M. Cardiac Rehab in the COVID-19 Pandemic. Am J Med 2021; 134: 559-560 DOI: 10.1016/j.amjmed.2021.01.007.
• 21 Schlitt A, Bestehorn K, Schwaab B. Situation der kardiologischen Rehabilitation im Rahmen der COVID-19-Pandemie in Deutschland – eine Blitzumfrage der Deutschen Gesellschaft für Rehabilitation und Prävention von Herz-Kreislauferkrankungen (DGPR) zur aktuellen Situation (August 2020). Z Evid Fortbild Qual Gesundhwes 2021; 164: 11-14 DOI: 10.1016/j.zefq.2021.04.005.
• 22 Riley H, Stabile L, Wu WC. Transition to Home-Based Treatment Plans for Center-Based Cardiac, Pulmonary, and Vascular Rehabilitation during COVID-19. R I Med J (2013) 2020; 103: 30-33
• 23 Ramachandran HJ, Jiang Y, Tam WWS. et al. Effectiveness of home-based cardiac telerehabilitation as an alternative to Phase 2 cardiac rehabilitation of coronary heart disease: a systematic review and meta-analysis. Eur J Prev Cardiol 2021; 13: zwab106 DOI: 10.1093/eurjpc/zwab106.
• 24 S3-Leitlinie zur kardiologischen Rehabilitation (LL-KardReha) im deutschsprachigen Raum Europas, Deutschland, Österreich, Schweiz (D-A-CH). Langversion. AWMF-Registernummer 133-001; 07.01.2020. Im Internet (Stand: 16.05.2022): https://www.awmf.org/leitlinien/detail/ll/133-001.html
• 25 Langheim E, Kleinschmidt J, Köllner V. Psychokardiologische Rehabilitation. In: Köllner V, Bassler M. Praxishandbuch Psychosomatische Medizin in der Rehabilitation. München: Elsevier; 2021: 340-346
• 26 Köllner V, Kleinschmidt J. Bewegung(stherapie) als Ressource in der Psychosomatischen Medizin. Ärztliche Psychotherapie 2021; 16: 150-155 DOI: 10.21706/aep-16-3-150.
• 27 Schroth S, Köllner V. Akzeptanz- und Commitment Therapie (ACT) bei körperlichen Erkrankungen. Ärztliche Psychotherapie 2020; 15: 177-183